全球微生物培养市场 - 2025 - 2032

2024年，全球微生物培养市场规模达74.3亿美元，预计2032年将达到131.9亿美元，2025-2032年预测期间复合年增长率为6.87%。

微生物培养透过在实验室环境中增加预设的生活方式介质来繁殖微生物。微生物培养用于确定生物体的类型、所研究模式内该生物体的丰度或两者。

微生物培养技术对于临床诊断、工业应用和科学研究等不同领域的微生物（特别是细菌）的研究和鑑定至关重要。这些技术涉及使用各种促进生长、分离和表征的培养基在受控环境中培养微生物。由于对精确诊断、新型抗生素开发和持续生物技术进步的需求不断增加，全球微生物培养市场正在经历显着增长。

市场动态：

驱动程式和限制

生物製药需求不断成长

微生物培养市场的成长受到几个关键因素的推动，其中主要驱动力之一是对生物製药的需求不断增长。微生物培养对于单株抗体、疫苗和重组蛋白等生物製药的生产至关重要。这种需求的增加需要专门的微生物菌株和培养物，有助于市场扩张。

生物加工技术的创新，特别是发酵和细胞培养技术，在推动市场方面也发挥着至关重要的作用。这些过程需要高品质的微生物培养物来提高效率和产量，进一步促进了对先进微生物培养物的需求。

此外，人们越来越重视依赖微生物培养物的生物製剂的再生医学，正在扩大这些培养物在治疗应用中的范围。随着再生医学的进步，对支持细胞疗法和组织再生的特定微生物培养物的需求不断增加。

随着生物製药行业的法规日益严格，对精确微生物测试和验证的需求也不断增长。这增加了在品质控制和保证方面对专门微生物培养的需求，以确保生物製药产品的安全性和有效性。

此外，微生物培养系统的持续创新，特别是在生物製药领域，正在推动市场向前发展。例如，2023年5月，HiMedia Laboratories与美国Advanced Instruments合作推出了Anoxomat III厌氧培养系统，这是一种旨在加强微生物学研究和培养管理的最先进系统。这些培养系统的创新有助于提高实验室效率并简化微生物检测。

开发成本高

开发先进的微生物培养物，尤其是生物製药和再生医学等专业应用，需要在研究、设备和确保合规性方面进行大量投资。对于中小型企业（SME）来说，这些高成本可能是一个主要障碍。他们往往缺乏资金来投资这些专业产品所需的必要基础设施或创新。这创造了一个环境，​​让拥有更多资本的大公司主导市场，限制竞争并减少微生物培养供应商的多样性。因此，中小企业可能难以创新或扩大生产规模，这可能会减缓整体市场成长并限制消费者可用的解决方案的范围。

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动力学

• 影响因素
  • 司机
    • 生物製药需求不断成长
  • 限制
    • 开发成本高
  • 机会
  • 影响分析

第 5 章：产业分析

• 波特五力分析
• 供应链分析
• 定价分析
• 专利分析
• 监管分析
• SWOT分析
• 未满足的需求

第 6 章：副产品

• 文化补品
• 培养仪器及设备
• 文化塑料
• 其他的

第 7 章：依文化媒体类型

• 简单媒体
• 合成媒体
• 复杂媒体
• 特殊媒体

第 8 章：一致性

• 液体培养基
• 半固体培养基
• 固体培养基

第 9 章：按申请

• 食品饮料业
• 水质测试
• 药品
• 化妆品
• 其他的

第 10 章：按地区

• 北美洲
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 欧洲其他地区
• 南美洲
  • 巴西
  • 阿根廷
  • 南美洲其他地区
• 亚太
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 中东和非洲

第 11 章：竞争格局

• 竞争场景
• 市场定位/份额分析
• 併购分析

第 12 章：公司简介

• Merck KGaA
• 公司概况
• 产品组合和描述
• 财务概览
• 主要进展
• Eiken Chemical Co, Ltd.
• Hi-Media Laboratories
• Neogen Corporation
• BD
• Thermo Fisher Scientific, Inc.
• Kerry Group
• bioMerieux
• Sartorius AG
• CONDALAB

第 13 章：附录

The global Microbiology Culture market reached US$ 7.43 billion in 2024 and is expected to reach US$ 13.19 billion by 2032, growing at a CAGR of 6.87% during the forecast period 2025-2032.

A microbiological culture multiplies microscopic organisms by increasing preset lifestyle media in a lab setting. Microbial cultures are used to determine the type of organism, the abundance of that organism within the pattern under investigation, or both.

Microbiology culture techniques are essential for studying and identifying microorganisms, particularly bacteria, across diverse sectors, including clinical diagnostics, industrial applications, and scientific research. These techniques involve the cultivation of microorganisms in controlled environments using various culture media that promote growth, isolation, and characterization. The global market for microbiology cultures is experiencing significant growth, driven by an increased need for precise diagnostics, novel antibiotics development, and ongoing biotechnology advancements.

Market Dynamics: Drivers & Restraints

Rising demand for biopharmaceuticals

The growth of the microbiology culture market is fueled by several key factors, with one of the primary drivers being the rising demand for biopharmaceuticals. Microbial cultures are essential in the production of biopharmaceuticals, such as monoclonal antibodies, vaccines, and recombinant proteins. This increased demand necessitates specialized microbial strains and cultures, contributing to market expansion.

Innovations in bioprocessing technologies, particularly fermentation and cell culture techniques, also play a crucial role in driving the market. These processes require high-quality microbial cultures to improve efficiency and output, further promoting the need for advanced microbiological cultures.

Additionally, the growing emphasis on regenerative medicine, which relies on biologics derived from microbial cultures, is expanding the scope of these cultures in therapeutic applications. As regenerative medicine advances, the demand for specific microbial cultures to support cell-based therapies and tissue regeneration is rising.

With increasingly stringent regulations in the biopharmaceutical industry, the demand for precise microbiological testing and validation is also growing. This has heightened the need for specialized microbial cultures in quality control and assurance, ensuring the safety and efficacy of biopharmaceutical products.

Furthermore, continuous innovations in microbiology culture systems, particularly in the biopharmaceutical sector, are driving the market forward. For example, in May 2023, HiMedia Laboratories partnered with US-based Advanced Instruments to launch the Anoxomat III Anaerobic Culture System, a state-of-the-art system designed to enhance microbiology research and culture management. These innovations in culture systems are helping improve laboratory efficiencies and streamline microbiological testing.

High development costs

Developing advanced microbial cultures, especially for specialized applications like biopharmaceuticals and regenerative medicine, involves significant investments in research, equipment, and ensuring regulatory compliance. For small and medium-sized enterprises (SMEs), these high costs can be a major barrier. They often lack the financial resources to invest in the necessary infrastructure or innovation required for these specialized products. This creates an environment where larger companies with more capital dominate the market, limiting competition and reducing the diversity of microbial culture suppliers. As a result, SMEs may struggle to innovate or scale up their production, which can slow overall market growth and limit the range of solutions available to consumers.

Segment Analysis

The global microbiology culture market is segmented based on product, culture media type, consistency, application, and region.

Product:

Food & beverage industry segment is expected to dominate the global microbiology culture share

Food & Beverage Industry segment is expected to dominate the microbiology culture market. As public awareness of food safety rises, producers are increasingly using microbiological testing to ensure that their products are safe. This demand creates a requirement for particular microbial cultures used in testing and quality assurance.

Culture media for food microbiology are crucial for ensuring food safety by detecting, isolating, and identifying microbes. Selective and differential culture media are critical in identifying potential pathogens and measuring microbial contamination levels, allowing for early intervention and prevention of foodborne diseases.

Microbiological cultures are essential for detecting contamination, ensuring product quality, and complying with strict food safety regulations imposed by authorities worldwide. With the growing demand for organic and minimally processed foods, the need for reliable microbiological testing to guarantee safety is also rising.

Furthermore, advancements in rapid detection technologies are making microbiological testing faster and more efficient, prompting food producers to adopt these methods to maintain safety standards and avoid costly product recalls. As a result, the food and beverage industry's commitment to maintaining high safety standards positions it as the dominant player in the microbiology culture market.

Geographical Analysis

North America is expected to hold a significant position in the global microbiology culture share.

This is due to the increasing testing with the increasing number of infections in the region. For instance, according to a report by the Centers for Disease Control and Prevention, it stated that Salmonella causes about 1.35 million illnesses, 26,500 hospitalizations, and 420 deaths in the United States every year.

Moreover, increased microbiological testing in the food and beverage industry has encouraged the expansion of the microbiology culture market in the United States.

The rising production of biopharmaceuticals is increasing the demand for microbiology cultures to study the antibiotic resistance of the particular organism against the drug and the increasing drug discovery is also expected to contribute the region's market growth. For instance, according to the data published by the Pharmaceutical Research and Manufacturers of America in 2024, it is stated that the U.S. biopharmaceutical industry exceeded $800 billion in direct output in 2022, and with the ripple effect of this production throughout the U.S. economy, supported an additional $850 billion in output through its suppliers and other sectors of the economy, for a total of more than $1.65 trillion. This combined, total output impact represents 3.6 percent of all U.S. output.

Asia Pacific is at the fastest growing pace in the global Microbiology Culture market share

Asia Pacific is currently experiencing the fastest growth in the global Microbiology Culture. The growing awareness of food safety and quality standards, coupled with stricter government regulations, has propelled the need for reliable microbiology culture methods to detect pathogens and ensure product safety. Additionally, the rise in healthcare infrastructure and research activities across Asia Pacific is contributing to the growing adoption of microbiology culture techniques for diagnostics, clinical applications, and scientific research.

Competitive Landscape

The major global players in the microbiology culture market include Merck KGaA, Eiken Chemical Co, Ltd., Hi-Media Laboratories, Neogen Corporation, BD, Thermo Fisher Scientific, Inc., Kerry Group, bioMerieux, Sartorius AG, and CONDALAB among others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global Microbiology Culture Market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product
• 3.2. Snippet by Culture Media Type
• 3.3. Snippet by Consistency
• 3.4. Snippet by Application
• 3.5. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Rising demand for biopharmaceuticals
  • 4.1.2. Restraints
    • 4.1.2.1. High development costs
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Patent Analysis
• 5.5. Regulatory Analysis
• 5.6. SWOT Analysis
• 5.7. Unmet Needs

6. By Product

• 6.1. Introduction
  • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Product
  • 6.1.2. Market Attractiveness Index, By Product
• 6.2. Culture Supplements*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Culture Instruments & Equipment
• 6.4. Culture Plastics
• 6.5. Others

7. By Culture Media Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Media Type
  • 7.1.2. Market Attractiveness Index, By Culture Media Type
• 7.2. Simple Media*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Synthetic Media
• 7.4. Complex Media
• 7.5. Special Media

8. By Consistency

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
  • 8.1.2. Market Attractiveness Index, By Consistency
• 8.2. Liquid Media*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Semi-solid Media
• 8.4. Solid Culture Media

9. By Application

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.1.2. Market Attractiveness Index, By Application
• 9.2. Food & Beverage Industry*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Water Testing
• 9.4. Pharmaceuticals
• 9.5. Cosmetics
• 9.6. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Media Type
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.7.1. U.S.
    • 10.2.7.2. Canada
    • 10.2.7.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Media Type
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.7.1. Germany
    • 10.3.7.2. U.K.
    • 10.3.7.3. France
    • 10.3.7.4. Spain
    • 10.3.7.5. Italy
    • 10.3.7.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Media Type
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.7.1. Brazil
    • 10.4.7.2. Argentina
    • 10.4.7.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Media Type
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.7.1. China
    • 10.5.7.2. India
    • 10.5.7.3. Japan
    • 10.5.7.4. South Korea
    • 10.5.7.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Media Type
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
  • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Merck KGaA*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Eiken Chemical Co, Ltd.
• 12.3. Hi-Media Laboratories
• 12.4. Neogen Corporation
• 12.5. BD
• 12.6. Thermo Fisher Scientific, Inc.
• 12.7. Kerry Group
• 12.8. bioMerieux
• 12.9. Sartorius AG
• 12.10. CONDALAB

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us